Well Told Grants

Federal grant programs / 21st Century Cures Act - Beau Biden Cancer Moonshot

21st Century Cures Act - Beau Biden Cancer Moonshot in Texas

21st Century Cures Act - Beau Biden Cancer Moonshot (93.353) awarded $31.4 million to recipients in Texas in 16 grants from fiscal 2021 to 2025, 6.4% of the program's national total. The Univeristy of Texas M.D. Anderson Cancer Center received the most, $24.4 million.

By year

Grants under this program to recipients in Texas
Fiscal yearAwardsAmount
FY 20216$3.5 million
FY 202210$6.6 million
FY 20239$7.8 million
FY 20246$5.3 million
FY 20255$8.2 million

Recipients in Texas

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
The Univeristy of Texas M.D. Anderson Cancer CenterColleges and universities10$24.4 million
The University of Texas Southwestern Medical CenterColleges and universities4$6.3 million
Sanarentero LLCSmall businesses1$399,999
Baylor College of MedicineColleges and universities1$320,000

Counted by the recipient's location. A recipient based in Texas may carry out the work elsewhere.

Open opportunities under this program

Questions people ask

How much 21st Century Cures Act - Beau Biden Cancer Moonshot money goes to Texas?

$31.4 million from fiscal 2021 to 2025, across 16 awards. Texas ranks 5th of 35 states and territories for this program.

Who receives 21st Century Cures Act - Beau Biden Cancer Moonshot money in Texas?

The largest recipient is The Univeristy of Texas M.D. Anderson Cancer Center, with $24.4 million in 10 awards. Next are The University of Texas Southwestern Medical Center and Sanarentero LLC.

Can organizations in Texas apply now?

Yes, 2 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

21st Century Cures Act - Beau Biden Cancer Moonshot in other states

Other large programs in Texas

All federal grants in Texas

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.